nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CHRM3—epilepsy syndrome	0.152	0.371	CbGaD
Pilocarpine—CHRM1—epilepsy syndrome	0.141	0.346	CbGaD
Pilocarpine—CHRM2—epilepsy syndrome	0.115	0.283	CbGaD
Pilocarpine—CYP2A6—Amobarbital—epilepsy syndrome	0.0329	0.0895	CbGbCtD
Pilocarpine—CYP2E1—Felbamate—epilepsy syndrome	0.0286	0.0779	CbGbCtD
Pilocarpine—CYP2E1—Trimethadione—epilepsy syndrome	0.0286	0.0779	CbGbCtD
Pilocarpine—CYP2A6—Propofol—epilepsy syndrome	0.0245	0.0667	CbGbCtD
Pilocarpine—CYP2E1—Clonazepam—epilepsy syndrome	0.0243	0.0663	CbGbCtD
Pilocarpine—CYP2A6—Phenobarbital—epilepsy syndrome	0.0234	0.0638	CbGbCtD
Pilocarpine—CYP2E1—Rufinamide—epilepsy syndrome	0.0198	0.054	CbGbCtD
Pilocarpine—CYP2A6—Valproic Acid—epilepsy syndrome	0.0175	0.0476	CbGbCtD
Pilocarpine—CYP2E1—Propofol—epilepsy syndrome	0.0162	0.044	CbGbCtD
Pilocarpine—CYP2E1—Phenobarbital—epilepsy syndrome	0.0155	0.0421	CbGbCtD
Pilocarpine—CYP2E1—Midazolam—epilepsy syndrome	0.0152	0.0415	CbGbCtD
Pilocarpine—CYP2E1—Diazepam—epilepsy syndrome	0.0147	0.0399	CbGbCtD
Pilocarpine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00933	0.0254	CbGbCtD
Pilocarpine—CYP3A4—Trimethadione—epilepsy syndrome	0.00867	0.0236	CbGbCtD
Pilocarpine—CYP3A4—Felbamate—epilepsy syndrome	0.00867	0.0236	CbGbCtD
Pilocarpine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00815	0.0222	CbGbCtD
Pilocarpine—CYP3A4—Clonazepam—epilepsy syndrome	0.00737	0.0201	CbGbCtD
Pilocarpine—CYP3A4—Clobazam—epilepsy syndrome	0.00707	0.0192	CbGbCtD
Pilocarpine—CYP3A4—Rufinamide—epilepsy syndrome	0.00601	0.0164	CbGbCtD
Pilocarpine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00586	0.0159	CbGbCtD
Pilocarpine—CYP3A4—Primidone—epilepsy syndrome	0.00547	0.0149	CbGbCtD
Pilocarpine—CYP3A4—Phenytoin—epilepsy syndrome	0.00525	0.0143	CbGbCtD
Pilocarpine—CYP3A4—Propofol—epilepsy syndrome	0.0049	0.0133	CbGbCtD
Pilocarpine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00468	0.0127	CbGbCtD
Pilocarpine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00468	0.0127	CbGbCtD
Pilocarpine—CYP3A4—Midazolam—epilepsy syndrome	0.00462	0.0126	CbGbCtD
Pilocarpine—CYP3A4—Diazepam—epilepsy syndrome	0.00444	0.0121	CbGbCtD
Pilocarpine—CYP3A4—Zonisamide—epilepsy syndrome	0.00433	0.0118	CbGbCtD
Pilocarpine—CYP3A4—Valproic Acid—epilepsy syndrome	0.0035	0.00953	CbGbCtD
Pilocarpine—CYP3A4—Topiramate—epilepsy syndrome	0.00316	0.0086	CbGbCtD
Pilocarpine—Asthenia—Phenytoin—epilepsy syndrome	3.19e-05	0.000187	CcSEcCtD
Pilocarpine—Nausea—Midazolam—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Pilocarpine—Hypoaesthesia—Topiramate—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Pilocarpine—Muscle spasms—Gabapentin—epilepsy syndrome	3.18e-05	0.000187	CcSEcCtD
Pilocarpine—Tachycardia—Valproic Acid—epilepsy syndrome	3.18e-05	0.000186	CcSEcCtD
Pilocarpine—Diarrhoea—Zonisamide—epilepsy syndrome	3.18e-05	0.000186	CcSEcCtD
Pilocarpine—Pharyngitis—Topiramate—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Pilocarpine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Pilocarpine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Pilocarpine—Pruritus—Clonazepam—epilepsy syndrome	3.17e-05	0.000186	CcSEcCtD
Pilocarpine—Vomiting—Vigabatrin—epilepsy syndrome	3.16e-05	0.000186	CcSEcCtD
Pilocarpine—Oedema peripheral—Topiramate—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Pilocarpine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Pilocarpine—Cough—Pregabalin—epilepsy syndrome	3.15e-05	0.000185	CcSEcCtD
Pilocarpine—Pruritus—Phenytoin—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Pilocarpine—Nausea—Levetiracetam—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Pilocarpine—Rash—Vigabatrin—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Pilocarpine—Dizziness—Felbamate—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Pilocarpine—Dermatitis—Vigabatrin—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Pilocarpine—Pruritus—Oxcarbazepine—epilepsy syndrome	3.13e-05	0.000183	CcSEcCtD
Pilocarpine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.13e-05	0.000183	CcSEcCtD
Pilocarpine—Vision blurred—Gabapentin—epilepsy syndrome	3.12e-05	0.000183	CcSEcCtD
Pilocarpine—Headache—Vigabatrin—epilepsy syndrome	3.12e-05	0.000183	CcSEcCtD
Pilocarpine—Hypertension—Pregabalin—epilepsy syndrome	3.12e-05	0.000183	CcSEcCtD
Pilocarpine—Vomiting—Diazepam—epilepsy syndrome	3.12e-05	0.000183	CcSEcCtD
Pilocarpine—Anorexia—Valproic Acid—epilepsy syndrome	3.11e-05	0.000182	CcSEcCtD
Pilocarpine—Tremor—Gabapentin—epilepsy syndrome	3.1e-05	0.000182	CcSEcCtD
Pilocarpine—Rash—Diazepam—epilepsy syndrome	3.09e-05	0.000181	CcSEcCtD
Pilocarpine—Dermatitis—Diazepam—epilepsy syndrome	3.09e-05	0.000181	CcSEcCtD
Pilocarpine—Visual impairment—Topiramate—epilepsy syndrome	3.08e-05	0.000181	CcSEcCtD
Pilocarpine—Arthralgia—Pregabalin—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Pilocarpine—Myalgia—Pregabalin—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Pilocarpine—Chest pain—Pregabalin—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Pilocarpine—Dizziness—Zonisamide—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Pilocarpine—Headache—Diazepam—epilepsy syndrome	3.07e-05	0.00018	CcSEcCtD
Pilocarpine—Anxiety—Pregabalin—epilepsy syndrome	3.06e-05	0.00018	CcSEcCtD
Pilocarpine—Diarrhoea—Clonazepam—epilepsy syndrome	3.06e-05	0.00018	CcSEcCtD
Pilocarpine—Hypotension—Valproic Acid—epilepsy syndrome	3.04e-05	0.000179	CcSEcCtD
Pilocarpine—Asthenia—Carbamazepine—epilepsy syndrome	3.04e-05	0.000179	CcSEcCtD
Pilocarpine—Agitation—Gabapentin—epilepsy syndrome	3.04e-05	0.000178	CcSEcCtD
Pilocarpine—Diarrhoea—Phenytoin—epilepsy syndrome	3.04e-05	0.000178	CcSEcCtD
Pilocarpine—Discomfort—Pregabalin—epilepsy syndrome	3.04e-05	0.000178	CcSEcCtD
Pilocarpine—Nausea—Fosphenytoin—epilepsy syndrome	3.03e-05	0.000178	CcSEcCtD
Pilocarpine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000177	CcSEcCtD
Pilocarpine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.02e-05	0.000177	CcSEcCtD
Pilocarpine—Vomiting—Felbamate—epilepsy syndrome	3.02e-05	0.000177	CcSEcCtD
Pilocarpine—Pruritus—Carbamazepine—epilepsy syndrome	3e-05	0.000176	CcSEcCtD
Pilocarpine—Rash—Felbamate—epilepsy syndrome	2.99e-05	0.000175	CcSEcCtD
Pilocarpine—Eye disorder—Topiramate—epilepsy syndrome	2.99e-05	0.000175	CcSEcCtD
Pilocarpine—Dermatitis—Felbamate—epilepsy syndrome	2.99e-05	0.000175	CcSEcCtD
Pilocarpine—Tinnitus—Topiramate—epilepsy syndrome	2.98e-05	0.000175	CcSEcCtD
Pilocarpine—Headache—Felbamate—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Pilocarpine—Confusional state—Pregabalin—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Pilocarpine—Flushing—Topiramate—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Pilocarpine—Syncope—Gabapentin—epilepsy syndrome	2.97e-05	0.000174	CcSEcCtD
Pilocarpine—Leukopenia—Gabapentin—epilepsy syndrome	2.96e-05	0.000174	CcSEcCtD
Pilocarpine—Dizziness—Clonazepam—epilepsy syndrome	2.96e-05	0.000174	CcSEcCtD
Pilocarpine—Nausea—Vigabatrin—epilepsy syndrome	2.96e-05	0.000173	CcSEcCtD
Pilocarpine—Vomiting—Zonisamide—epilepsy syndrome	2.95e-05	0.000173	CcSEcCtD
Pilocarpine—Insomnia—Valproic Acid—epilepsy syndrome	2.95e-05	0.000173	CcSEcCtD
Pilocarpine—Oedema—Pregabalin—epilepsy syndrome	2.95e-05	0.000173	CcSEcCtD
Pilocarpine—Asthenia—Lamotrigine—epilepsy syndrome	2.94e-05	0.000173	CcSEcCtD
Pilocarpine—Dizziness—Phenytoin—epilepsy syndrome	2.94e-05	0.000172	CcSEcCtD
Pilocarpine—Rash—Zonisamide—epilepsy syndrome	2.93e-05	0.000172	CcSEcCtD
Pilocarpine—Infection—Pregabalin—epilepsy syndrome	2.93e-05	0.000172	CcSEcCtD
Pilocarpine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.93e-05	0.000172	CcSEcCtD
Pilocarpine—Palpitations—Gabapentin—epilepsy syndrome	2.92e-05	0.000172	CcSEcCtD
Pilocarpine—Dermatitis—Zonisamide—epilepsy syndrome	2.92e-05	0.000172	CcSEcCtD
Pilocarpine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.92e-05	0.000171	CcSEcCtD
Pilocarpine—Nausea—Diazepam—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Pilocarpine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Pilocarpine—Headache—Zonisamide—epilepsy syndrome	2.91e-05	0.000171	CcSEcCtD
Pilocarpine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Pilocarpine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Pilocarpine—Pruritus—Lamotrigine—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Pilocarpine—Shock—Pregabalin—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Pilocarpine—Somnolence—Valproic Acid—epilepsy syndrome	2.9e-05	0.00017	CcSEcCtD
Pilocarpine—Cough—Gabapentin—epilepsy syndrome	2.89e-05	0.000169	CcSEcCtD
Pilocarpine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.88e-05	0.000169	CcSEcCtD
Pilocarpine—Tachycardia—Pregabalin—epilepsy syndrome	2.87e-05	0.000169	CcSEcCtD
Pilocarpine—Chills—Topiramate—epilepsy syndrome	2.87e-05	0.000168	CcSEcCtD
Pilocarpine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.87e-05	0.000168	CcSEcCtD
Pilocarpine—Hypertension—Gabapentin—epilepsy syndrome	2.86e-05	0.000168	CcSEcCtD
Pilocarpine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.85e-05	0.000167	CcSEcCtD
Pilocarpine—Vomiting—Clonazepam—epilepsy syndrome	2.84e-05	0.000167	CcSEcCtD
Pilocarpine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.83e-05	0.000166	CcSEcCtD
Pilocarpine—Alopecia—Topiramate—epilepsy syndrome	2.83e-05	0.000166	CcSEcCtD
Pilocarpine—Vomiting—Phenytoin—epilepsy syndrome	2.83e-05	0.000166	CcSEcCtD
Pilocarpine—Rash—Clonazepam—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Dermatitis—Clonazepam—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Arthralgia—Gabapentin—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Chest pain—Gabapentin—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Myalgia—Gabapentin—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Nausea—Felbamate—epilepsy syndrome	2.82e-05	0.000165	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Pilocarpine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Pilocarpine—Anxiety—Gabapentin—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Pilocarpine—Anorexia—Pregabalin—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Pilocarpine—Dizziness—Carbamazepine—epilepsy syndrome	2.81e-05	0.000165	CcSEcCtD
Pilocarpine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.8e-05	0.000165	CcSEcCtD
Pilocarpine—Headache—Clonazepam—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Pilocarpine—Rash—Phenytoin—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Pilocarpine—Dermatitis—Phenytoin—epilepsy syndrome	2.8e-05	0.000164	CcSEcCtD
Pilocarpine—Rash—Oxcarbazepine—epilepsy syndrome	2.79e-05	0.000163	CcSEcCtD
Pilocarpine—Constipation—Valproic Acid—epilepsy syndrome	2.79e-05	0.000163	CcSEcCtD
Pilocarpine—Pain—Valproic Acid—epilepsy syndrome	2.79e-05	0.000163	CcSEcCtD
Pilocarpine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Pilocarpine—Headache—Phenytoin—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Pilocarpine—Discomfort—Gabapentin—epilepsy syndrome	2.78e-05	0.000163	CcSEcCtD
Pilocarpine—Headache—Oxcarbazepine—epilepsy syndrome	2.77e-05	0.000162	CcSEcCtD
Pilocarpine—Nausea—Zonisamide—epilepsy syndrome	2.76e-05	0.000162	CcSEcCtD
Pilocarpine—Hypotension—Pregabalin—epilepsy syndrome	2.75e-05	0.000161	CcSEcCtD
Pilocarpine—Flatulence—Topiramate—epilepsy syndrome	2.74e-05	0.000161	CcSEcCtD
Pilocarpine—Tension—Topiramate—epilepsy syndrome	2.73e-05	0.00016	CcSEcCtD
Pilocarpine—Dysgeusia—Topiramate—epilepsy syndrome	2.73e-05	0.00016	CcSEcCtD
Pilocarpine—Confusional state—Gabapentin—epilepsy syndrome	2.72e-05	0.00016	CcSEcCtD
Pilocarpine—Dizziness—Lamotrigine—epilepsy syndrome	2.71e-05	0.000159	CcSEcCtD
Pilocarpine—Nervousness—Topiramate—epilepsy syndrome	2.7e-05	0.000159	CcSEcCtD
Pilocarpine—Oedema—Gabapentin—epilepsy syndrome	2.7e-05	0.000158	CcSEcCtD
Pilocarpine—Vomiting—Carbamazepine—epilepsy syndrome	2.7e-05	0.000158	CcSEcCtD
Pilocarpine—Back pain—Topiramate—epilepsy syndrome	2.69e-05	0.000158	CcSEcCtD
Pilocarpine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Pilocarpine—Infection—Gabapentin—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Pilocarpine—Muscle spasms—Topiramate—epilepsy syndrome	2.68e-05	0.000157	CcSEcCtD
Pilocarpine—Rash—Carbamazepine—epilepsy syndrome	2.67e-05	0.000157	CcSEcCtD
Pilocarpine—Dermatitis—Carbamazepine—epilepsy syndrome	2.67e-05	0.000157	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Pilocarpine—Insomnia—Pregabalin—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Pilocarpine—Nausea—Clonazepam—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Pilocarpine—Headache—Carbamazepine—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Pilocarpine—Shock—Gabapentin—epilepsy syndrome	2.66e-05	0.000156	CcSEcCtD
Pilocarpine—Paraesthesia—Pregabalin—epilepsy syndrome	2.64e-05	0.000155	CcSEcCtD
Pilocarpine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.64e-05	0.000155	CcSEcCtD
Pilocarpine—Nausea—Phenytoin—epilepsy syndrome	2.64e-05	0.000155	CcSEcCtD
Pilocarpine—Tachycardia—Gabapentin—epilepsy syndrome	2.64e-05	0.000155	CcSEcCtD
Pilocarpine—Dyspnoea—Pregabalin—epilepsy syndrome	2.63e-05	0.000154	CcSEcCtD
Pilocarpine—Nausea—Oxcarbazepine—epilepsy syndrome	2.63e-05	0.000154	CcSEcCtD
Pilocarpine—Vision blurred—Topiramate—epilepsy syndrome	2.62e-05	0.000154	CcSEcCtD
Pilocarpine—CHRM2—forebrain—epilepsy syndrome	2.62e-05	0.0663	CbGeAlD
Pilocarpine—Somnolence—Pregabalin—epilepsy syndrome	2.62e-05	0.000154	CcSEcCtD
Pilocarpine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Pilocarpine—Tremor—Topiramate—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Pilocarpine—Vomiting—Lamotrigine—epilepsy syndrome	2.61e-05	0.000153	CcSEcCtD
Pilocarpine—Rash—Lamotrigine—epilepsy syndrome	2.58e-05	0.000152	CcSEcCtD
Pilocarpine—Dermatitis—Lamotrigine—epilepsy syndrome	2.58e-05	0.000151	CcSEcCtD
Pilocarpine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.58e-05	0.000151	CcSEcCtD
Pilocarpine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.58e-05	0.000151	CcSEcCtD
Pilocarpine—Anorexia—Gabapentin—epilepsy syndrome	2.57e-05	0.000151	CcSEcCtD
Pilocarpine—Headache—Lamotrigine—epilepsy syndrome	2.57e-05	0.000151	CcSEcCtD
Pilocarpine—Decreased appetite—Pregabalin—epilepsy syndrome	2.56e-05	0.00015	CcSEcCtD
Pilocarpine—Agitation—Topiramate—epilepsy syndrome	2.56e-05	0.00015	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.54e-05	0.000149	CcSEcCtD
Pilocarpine—Hypotension—Gabapentin—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Pilocarpine—Nausea—Carbamazepine—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Pilocarpine—Constipation—Pregabalin—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Pilocarpine—Pain—Pregabalin—epilepsy syndrome	2.52e-05	0.000148	CcSEcCtD
Pilocarpine—Syncope—Topiramate—epilepsy syndrome	2.5e-05	0.000146	CcSEcCtD
Pilocarpine—Leukopenia—Topiramate—epilepsy syndrome	2.49e-05	0.000146	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.46e-05	0.000144	CcSEcCtD
Pilocarpine—Palpitations—Topiramate—epilepsy syndrome	2.46e-05	0.000144	CcSEcCtD
Pilocarpine—Loss of consciousness—Topiramate—epilepsy syndrome	2.45e-05	0.000144	CcSEcCtD
Pilocarpine—Insomnia—Gabapentin—epilepsy syndrome	2.44e-05	0.000143	CcSEcCtD
Pilocarpine—Nausea—Lamotrigine—epilepsy syndrome	2.44e-05	0.000143	CcSEcCtD
Pilocarpine—Cough—Topiramate—epilepsy syndrome	2.43e-05	0.000142	CcSEcCtD
Pilocarpine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.43e-05	0.000142	CcSEcCtD
Pilocarpine—Paraesthesia—Gabapentin—epilepsy syndrome	2.42e-05	0.000142	CcSEcCtD
Pilocarpine—CHRM2—telencephalon—epilepsy syndrome	2.41e-05	0.0609	CbGeAlD
Pilocarpine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.41e-05	0.000141	CcSEcCtD
Pilocarpine—Dyspnoea—Gabapentin—epilepsy syndrome	2.41e-05	0.000141	CcSEcCtD
Pilocarpine—Hypertension—Topiramate—epilepsy syndrome	2.4e-05	0.000141	CcSEcCtD
Pilocarpine—Somnolence—Gabapentin—epilepsy syndrome	2.4e-05	0.000141	CcSEcCtD
Pilocarpine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.4e-05	0.000141	CcSEcCtD
Pilocarpine—CHRM1—forebrain—epilepsy syndrome	2.39e-05	0.0603	CbGeAlD
Pilocarpine—Dyspepsia—Gabapentin—epilepsy syndrome	2.38e-05	0.000139	CcSEcCtD
Pilocarpine—Chest pain—Topiramate—epilepsy syndrome	2.37e-05	0.000139	CcSEcCtD
Pilocarpine—Myalgia—Topiramate—epilepsy syndrome	2.37e-05	0.000139	CcSEcCtD
Pilocarpine—Arthralgia—Topiramate—epilepsy syndrome	2.37e-05	0.000139	CcSEcCtD
Pilocarpine—Anxiety—Topiramate—epilepsy syndrome	2.36e-05	0.000139	CcSEcCtD
Pilocarpine—Decreased appetite—Gabapentin—epilepsy syndrome	2.35e-05	0.000138	CcSEcCtD
Pilocarpine—Discomfort—Topiramate—epilepsy syndrome	2.34e-05	0.000137	CcSEcCtD
Pilocarpine—Asthenia—Valproic Acid—epilepsy syndrome	2.34e-05	0.000137	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.33e-05	0.000137	CcSEcCtD
Pilocarpine—Abdominal pain—Pregabalin—epilepsy syndrome	2.33e-05	0.000137	CcSEcCtD
Pilocarpine—Body temperature increased—Pregabalin—epilepsy syndrome	2.33e-05	0.000137	CcSEcCtD
Pilocarpine—Pain—Gabapentin—epilepsy syndrome	2.31e-05	0.000135	CcSEcCtD
Pilocarpine—Constipation—Gabapentin—epilepsy syndrome	2.31e-05	0.000135	CcSEcCtD
Pilocarpine—Pruritus—Valproic Acid—epilepsy syndrome	2.3e-05	0.000135	CcSEcCtD
Pilocarpine—Confusional state—Topiramate—epilepsy syndrome	2.29e-05	0.000134	CcSEcCtD
Pilocarpine—Oedema—Topiramate—epilepsy syndrome	2.27e-05	0.000133	CcSEcCtD
Pilocarpine—Infection—Topiramate—epilepsy syndrome	2.26e-05	0.000132	CcSEcCtD
Pilocarpine—Shock—Topiramate—epilepsy syndrome	2.24e-05	0.000131	CcSEcCtD
Pilocarpine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.23e-05	0.000131	CcSEcCtD
Pilocarpine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.23e-05	0.000131	CcSEcCtD
Pilocarpine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.22e-05	0.00013	CcSEcCtD
Pilocarpine—Tachycardia—Topiramate—epilepsy syndrome	2.22e-05	0.00013	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.21e-05	0.00013	CcSEcCtD
Pilocarpine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.2e-05	0.000129	CcSEcCtD
Pilocarpine—CHRM1—telencephalon—epilepsy syndrome	2.19e-05	0.0555	CbGeAlD
Pilocarpine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.17e-05	0.000127	CcSEcCtD
Pilocarpine—Anorexia—Topiramate—epilepsy syndrome	2.17e-05	0.000127	CcSEcCtD
Pilocarpine—Dizziness—Valproic Acid—epilepsy syndrome	2.15e-05	0.000126	CcSEcCtD
Pilocarpine—Abdominal pain—Gabapentin—epilepsy syndrome	2.13e-05	0.000125	CcSEcCtD
Pilocarpine—Body temperature increased—Gabapentin—epilepsy syndrome	2.13e-05	0.000125	CcSEcCtD
Pilocarpine—CHRM3—forebrain—epilepsy syndrome	2.13e-05	0.054	CbGeAlD
Pilocarpine—Hypotension—Topiramate—epilepsy syndrome	2.12e-05	0.000125	CcSEcCtD
Pilocarpine—Asthenia—Pregabalin—epilepsy syndrome	2.11e-05	0.000124	CcSEcCtD
Pilocarpine—Pruritus—Pregabalin—epilepsy syndrome	2.08e-05	0.000122	CcSEcCtD
Pilocarpine—Vomiting—Valproic Acid—epilepsy syndrome	2.07e-05	0.000121	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.07e-05	0.000121	CcSEcCtD
Pilocarpine—Insomnia—Topiramate—epilepsy syndrome	2.05e-05	0.000121	CcSEcCtD
Pilocarpine—Rash—Valproic Acid—epilepsy syndrome	2.05e-05	0.00012	CcSEcCtD
Pilocarpine—Dermatitis—Valproic Acid—epilepsy syndrome	2.05e-05	0.00012	CcSEcCtD
Pilocarpine—Headache—Valproic Acid—epilepsy syndrome	2.04e-05	0.00012	CcSEcCtD
Pilocarpine—Paraesthesia—Topiramate—epilepsy syndrome	2.04e-05	0.00012	CcSEcCtD
Pilocarpine—Dyspnoea—Topiramate—epilepsy syndrome	2.03e-05	0.000119	CcSEcCtD
Pilocarpine—Somnolence—Topiramate—epilepsy syndrome	2.02e-05	0.000118	CcSEcCtD
Pilocarpine—Diarrhoea—Pregabalin—epilepsy syndrome	2.02e-05	0.000118	CcSEcCtD
Pilocarpine—Dyspepsia—Topiramate—epilepsy syndrome	2e-05	0.000117	CcSEcCtD
Pilocarpine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.99e-05	0.000117	CcSEcCtD
Pilocarpine—Decreased appetite—Topiramate—epilepsy syndrome	1.98e-05	0.000116	CcSEcCtD
Pilocarpine—CHRM3—telencephalon—epilepsy syndrome	1.96e-05	0.0496	CbGeAlD
Pilocarpine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.96e-05	0.000115	CcSEcCtD
Pilocarpine—Dizziness—Pregabalin—epilepsy syndrome	1.95e-05	0.000114	CcSEcCtD
Pilocarpine—Pain—Topiramate—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Pilocarpine—Constipation—Topiramate—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Pilocarpine—Asthenia—Gabapentin—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Pilocarpine—Nausea—Valproic Acid—epilepsy syndrome	1.94e-05	0.000114	CcSEcCtD
Pilocarpine—Pruritus—Gabapentin—epilepsy syndrome	1.91e-05	0.000112	CcSEcCtD
Pilocarpine—Vomiting—Pregabalin—epilepsy syndrome	1.87e-05	0.00011	CcSEcCtD
Pilocarpine—Feeling abnormal—Topiramate—epilepsy syndrome	1.87e-05	0.00011	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.86e-05	0.000109	CcSEcCtD
Pilocarpine—Rash—Pregabalin—epilepsy syndrome	1.86e-05	0.000109	CcSEcCtD
Pilocarpine—Dermatitis—Pregabalin—epilepsy syndrome	1.86e-05	0.000109	CcSEcCtD
Pilocarpine—Diarrhoea—Gabapentin—epilepsy syndrome	1.85e-05	0.000108	CcSEcCtD
Pilocarpine—Headache—Pregabalin—epilepsy syndrome	1.85e-05	0.000108	CcSEcCtD
Pilocarpine—Abdominal pain—Topiramate—epilepsy syndrome	1.8e-05	0.000105	CcSEcCtD
Pilocarpine—Body temperature increased—Topiramate—epilepsy syndrome	1.8e-05	0.000105	CcSEcCtD
Pilocarpine—Dizziness—Gabapentin—epilepsy syndrome	1.79e-05	0.000105	CcSEcCtD
Pilocarpine—Nausea—Pregabalin—epilepsy syndrome	1.75e-05	0.000103	CcSEcCtD
Pilocarpine—Vomiting—Gabapentin—epilepsy syndrome	1.72e-05	0.000101	CcSEcCtD
Pilocarpine—Rash—Gabapentin—epilepsy syndrome	1.7e-05	9.99e-05	CcSEcCtD
Pilocarpine—Dermatitis—Gabapentin—epilepsy syndrome	1.7e-05	9.98e-05	CcSEcCtD
Pilocarpine—Headache—Gabapentin—epilepsy syndrome	1.69e-05	9.92e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Topiramate—epilepsy syndrome	1.67e-05	9.82e-05	CcSEcCtD
Pilocarpine—Asthenia—Topiramate—epilepsy syndrome	1.63e-05	9.56e-05	CcSEcCtD
Pilocarpine—Pruritus—Topiramate—epilepsy syndrome	1.61e-05	9.43e-05	CcSEcCtD
Pilocarpine—Nausea—Gabapentin—epilepsy syndrome	1.6e-05	9.41e-05	CcSEcCtD
Pilocarpine—CYP2A6—cerebellum—epilepsy syndrome	1.58e-05	0.0399	CbGeAlD
Pilocarpine—Diarrhoea—Topiramate—epilepsy syndrome	1.55e-05	9.12e-05	CcSEcCtD
Pilocarpine—Dizziness—Topiramate—epilepsy syndrome	1.5e-05	8.81e-05	CcSEcCtD
Pilocarpine—CHRM2—head—epilepsy syndrome	1.5e-05	0.038	CbGeAlD
Pilocarpine—Vomiting—Topiramate—epilepsy syndrome	1.44e-05	8.47e-05	CcSEcCtD
Pilocarpine—Rash—Topiramate—epilepsy syndrome	1.43e-05	8.4e-05	CcSEcCtD
Pilocarpine—Dermatitis—Topiramate—epilepsy syndrome	1.43e-05	8.4e-05	CcSEcCtD
Pilocarpine—Headache—Topiramate—epilepsy syndrome	1.42e-05	8.35e-05	CcSEcCtD
Pilocarpine—CHRM2—nervous system—epilepsy syndrome	1.42e-05	0.036	CbGeAlD
Pilocarpine—CHRM2—central nervous system—epilepsy syndrome	1.37e-05	0.0346	CbGeAlD
Pilocarpine—CHRM1—head—epilepsy syndrome	1.37e-05	0.0345	CbGeAlD
Pilocarpine—Nausea—Topiramate—epilepsy syndrome	1.35e-05	7.92e-05	CcSEcCtD
Pilocarpine—CYP2E1—telencephalon—epilepsy syndrome	1.34e-05	0.0339	CbGeAlD
Pilocarpine—CHRM1—nervous system—epilepsy syndrome	1.3e-05	0.0328	CbGeAlD
Pilocarpine—CYP2A6—brain—epilepsy syndrome	1.28e-05	0.0324	CbGeAlD
Pilocarpine—CHRM1—central nervous system—epilepsy syndrome	1.25e-05	0.0315	CbGeAlD
Pilocarpine—CHRM3—head—epilepsy syndrome	1.22e-05	0.0309	CbGeAlD
Pilocarpine—CHRM3—nervous system—epilepsy syndrome	1.16e-05	0.0293	CbGeAlD
Pilocarpine—CHRM3—central nervous system—epilepsy syndrome	1.12e-05	0.0282	CbGeAlD
Pilocarpine—CHRM2—brain—epilepsy syndrome	1.09e-05	0.0275	CbGeAlD
Pilocarpine—CYP2E1—medulla oblongata—epilepsy syndrome	1.05e-05	0.0266	CbGeAlD
Pilocarpine—CHRM1—brain—epilepsy syndrome	9.9e-06	0.025	CbGeAlD
Pilocarpine—CYP2E1—spinal cord—epilepsy syndrome	9.39e-06	0.0238	CbGeAlD
Pilocarpine—CHRM3—brain—epilepsy syndrome	8.86e-06	0.0224	CbGeAlD
Pilocarpine—CYP2E1—head—epilepsy syndrome	8.35e-06	0.0211	CbGeAlD
Pilocarpine—CYP2E1—nervous system—epilepsy syndrome	7.91e-06	0.02	CbGeAlD
Pilocarpine—CYP2E1—central nervous system—epilepsy syndrome	7.62e-06	0.0193	CbGeAlD
Pilocarpine—CYP2E1—cerebellum—epilepsy syndrome	7.45e-06	0.0188	CbGeAlD
Pilocarpine—CYP3A4—nervous system—epilepsy syndrome	6.37e-06	0.0161	CbGeAlD
Pilocarpine—CYP3A4—central nervous system—epilepsy syndrome	6.13e-06	0.0155	CbGeAlD
Pilocarpine—CYP2E1—brain—epilepsy syndrome	6.05e-06	0.0153	CbGeAlD
Pilocarpine—CHRM3—Metabolism—PLCB1—epilepsy syndrome	6.01e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TH—epilepsy syndrome	5.99e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	5.98e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	5.96e-06	0.000111	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.92e-06	0.000111	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	5.9e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	5.85e-06	0.000109	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	5.83e-06	0.000109	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.78e-06	0.000108	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.72e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.72e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	5.66e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.65e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.64e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.64e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.63e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	5.62e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	5.62e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.58e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	5.56e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	5.56e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.55e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	5.54e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.48e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.48e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.48e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	5.48e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	5.47e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	5.47e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	5.47e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5.43e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	5.42e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	5.41e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	5.41e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	5.41e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	5.39e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.38e-06	0.0001	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	5.37e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.37e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	5.36e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	5.35e-06	9.99e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	5.34e-06	9.98e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	5.33e-06	9.96e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	5.33e-06	9.95e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.3e-06	9.9e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	5.27e-06	9.86e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CAT—epilepsy syndrome	5.26e-06	9.83e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.23e-06	9.78e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	5.16e-06	9.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	5.16e-06	9.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	5.15e-06	9.62e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	5.14e-06	9.6e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	5.14e-06	9.6e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	5.13e-06	9.59e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	5.13e-06	9.59e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	5.12e-06	9.57e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	5.12e-06	9.56e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	5.12e-06	9.56e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	5.11e-06	9.55e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.1e-06	9.53e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.1e-06	9.53e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	5.09e-06	9.52e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.09e-06	9.51e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	5.09e-06	9.51e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	5.08e-06	9.49e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.07e-06	9.46e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	5.06e-06	9.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	5.06e-06	9.45e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	5.06e-06	9.45e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TH—epilepsy syndrome	5.05e-06	9.43e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.05e-06	9.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	5.04e-06	9.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	5.04e-06	9.42e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	5.04e-06	9.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	5.03e-06	9.39e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	5e-06	9.34e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.99e-06	9.33e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.99e-06	9.33e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.98e-06	9.3e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.94e-06	9.22e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CAT—epilepsy syndrome	4.93e-06	9.21e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.92e-06	9.19e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.87e-06	9.11e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.86e-06	9.09e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.86e-06	9.09e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.8e-06	8.96e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.79e-06	8.95e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.78e-06	8.93e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.76e-06	8.89e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	4.76e-06	8.89e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.73e-06	8.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.7e-06	8.79e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.69e-06	8.76e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.67e-06	8.73e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.66e-06	8.71e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.66e-06	8.71e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.64e-06	8.68e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.61e-06	8.62e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.59e-06	8.59e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.58e-06	8.56e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.57e-06	8.55e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.57e-06	8.55e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.56e-06	8.52e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.54e-06	8.47e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.51e-06	8.44e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.49e-06	8.39e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.46e-06	8.33e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.34e-06	8.12e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4.33e-06	8.09e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	4.3e-06	8.04e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	4.29e-06	8.02e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	4.29e-06	8.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	4.29e-06	8.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	4.28e-06	7.99e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	4.25e-06	7.94e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	4.24e-06	7.92e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	4.21e-06	7.87e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.2e-06	7.85e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AGT—epilepsy syndrome	4.17e-06	7.79e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CAT—epilepsy syndrome	4.16e-06	7.76e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	4.16e-06	7.76e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	4.14e-06	7.74e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	4.1e-06	7.66e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—APOE—epilepsy syndrome	4.09e-06	7.63e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.08e-06	7.62e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	4.04e-06	7.55e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.93e-06	7.34e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.92e-06	7.32e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AGT—epilepsy syndrome	3.91e-06	7.31e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.88e-06	7.25e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOE—epilepsy syndrome	3.83e-06	7.16e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.82e-06	7.14e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.81e-06	7.12e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.81e-06	7.11e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.8e-06	7.1e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.8e-06	7.09e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.79e-06	7.08e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.77e-06	7.05e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.76e-06	7.02e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.76e-06	7.02e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.75e-06	7.01e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.69e-06	6.89e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.69e-06	6.89e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.67e-06	6.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.66e-06	6.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.63e-06	6.79e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.63e-06	6.77e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.62e-06	6.76e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.59e-06	6.7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.53e-06	6.6e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.52e-06	6.58e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—POMC—epilepsy syndrome	3.51e-06	6.56e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.49e-06	6.52e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.46e-06	6.46e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.45e-06	6.44e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.41e-06	6.38e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AGT—epilepsy syndrome	3.3e-06	6.16e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—POMC—epilepsy syndrome	3.29e-06	6.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.28e-06	6.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.28e-06	6.13e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.27e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.27e-06	6.11e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	3.24e-06	6.06e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	3.24e-06	6.05e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOE—epilepsy syndrome	3.23e-06	6.03e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	3.21e-06	6.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	3.2e-06	5.99e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—epilepsy syndrome	3.2e-06	5.98e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	3.17e-06	5.93e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	3.15e-06	5.88e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	3.14e-06	5.87e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	3.11e-06	5.81e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	3.03e-06	5.66e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	3.02e-06	5.65e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	3.02e-06	5.64e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	3.01e-06	5.62e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.01e-06	5.62e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—epilepsy syndrome	3e-06	5.61e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.99e-06	5.59e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.98e-06	5.57e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.93e-06	5.47e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.91e-06	5.44e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	2.8e-06	5.23e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.77e-06	5.18e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.76e-06	5.16e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.75e-06	5.14e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.73e-06	5.09e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.7e-06	5.05e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.69e-06	5.03e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.67e-06	4.98e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.63e-06	4.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.63e-06	4.91e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.53e-06	4.73e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.5e-06	4.67e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.49e-06	4.65e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.44e-06	4.56e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.43e-06	4.55e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.41e-06	4.5e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.38e-06	4.44e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.35e-06	4.39e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.34e-06	4.37e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.27e-06	4.24e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.26e-06	4.22e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.24e-06	4.18e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.22e-06	4.15e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.22e-06	4.14e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	2.21e-06	4.13e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.19e-06	4.1e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.06e-06	3.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.06e-06	3.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.04e-06	3.82e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.04e-06	3.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.04e-06	3.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.02e-06	3.77e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.99e-06	3.71e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.98e-06	3.7e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.96e-06	3.66e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	3.65e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.93e-06	3.61e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.93e-06	3.6e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.93e-06	3.6e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.91e-06	3.56e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.88e-06	3.5e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.87e-06	3.5e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.87e-06	3.49e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.85e-06	3.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.78e-06	3.33e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.78e-06	3.32e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.76e-06	3.29e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.74e-06	3.26e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.73e-06	3.24e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.73e-06	3.23e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.71e-06	3.2e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.53e-06	2.86e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.5e-06	2.8e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.41e-06	2.63e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.32e-06	2.47e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.29e-06	2.4e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.17e-06	2.19e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	1.11e-06	2.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.11e-06	2.07e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.1e-06	2.06e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.09e-06	2.04e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	1.92e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.16e-07	9.64e-06	CbGpPWpGaD
